Filtros de búsqueda

Lista de obras de Geoffrey Liu

A Large-scale genetic association study of esophageal adenocarcinoma risk

artículo científico publicado en 2010

A comprehensive catalogue of functional genetic variations in the EGFR pathway: protein-protein interaction analysis reveals novel genes and polymorphisms important for cancer research

artículo científico publicado en 2009

A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer

artículo científico publicado en 2015

A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome

artículo científico publicado en 2008

A genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC).

artículo científico publicado en 2014

A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus

scientific journal article

A genome-wide association study of non-HPV-related head and neck squamous cell carcinoma identifies prognostic genetic sequence variants in the MAP-kinase and hormone pathways.

artículo científico publicado en 2016

A phase I study of foretinib plus erlotinib in patients with previously treated advanced non-small cell lung cancer: Canadian cancer trials group IND.196.

artículo científico publicado en 2017

A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503).

artículo científico publicado en 2013

A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancer

artículo científico publicado en 2012

A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia

artículo científico publicado en 2015

A rapid outcomes ascertainment system improves the quality of prognostic and pharmacogenetic outcomes from observational studies.

artículo científico publicado en 2008

A systematic review and Canadian consensus recommendations on the use of biomarkers in the treatment of non-small cell lung cancer.

artículo científico publicado en 2011

A window of opportunity study of potential tumor and soluble biomarkers of response to preoperative erlotinib in early stage non-small cell lung cancer

scientific article published on 25 March 2016

ABCC2 polymorphisms and survival in the Princess Margaret cohort study and the NCIC clinical trials group BR.24 trial of platinum-treated advanced stage non-small cell lung cancer patients.

artículo científico publicado en 2016

ALK-Rearranged Non-Small-Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism

artículo científico publicado en 2016

Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial

artículo científico publicado en 2016

Algorithms for systematic identification of small subgraphs

artículo científico

An association between glutathione S-transferase P1 gene polymorphism and younger age at onset of lung carcinoma

artículo científico publicado en 2006

Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer

artículo científico publicado en 2008

Appropriateness of using patient-derived xenograft models for pharmacologic evaluation of novel therapies for esophageal/gastro-esophageal junction cancers

artículo científico publicado en 2015

Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium

artículo científico publicado en 2015

Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer.

artículo científico publicado en 2017

Association analysis of driver-gene related genetic variants identified novel lung cancer susceptibility loci with 20,871 lung cancer cases and 15,971 controls

scientific article published on 10 April 2020

Association between UGT1A1*28 polymorphisms and clinical outcomes of irinotecan-based chemotherapies in colorectal cancer: a meta-analysis in Caucasians

artículo científico publicado en 2013

Association between a 15q25 gene variant, smoking quantity and tobacco-related cancers among 17 000 individuals

artículo científico publicado en 2009

Association between polymorphisms in cancer-related genes and early onset of esophageal adenocarcinoma

artículo científico publicado en 2011

Association between time to progression and subsequent survival inceritinib-treated patients with advanced ALK-positive non-small-cell lung cancer

artículo científico publicado en 2016

Association of BRM promoter polymorphisms and esophageal adenocarcinoma outcome

artículo científico publicado en 2017

Association of MDM2 T309G and p53 Arg72Pro polymorphisms and gastroesophageal reflux disease with survival in esophageal adenocarcinoma

artículo científico publicado en 2013

Association of UGT1A1*28 polymorphisms with irinotecan-induced toxicities in colorectal cancer: a meta-analysis in Caucasians

artículo científico publicado en 2013

Association of the 15q25 and 5p15 lung cancer susceptibility regions with gene expression in lung tumor tissue

artículo científico publicado en 2012

Association of two BRM promoter polymorphisms with head and neck squamous cell carcinoma risk

artículo científico publicado en 2013

BRM Promoter Polymorphisms and Survival of Advanced Non-Small Cell Lung Cancer Patients in the Princess Margaret Cohort and CCTG BR.24 Trial

artículo científico publicado en 2016

BRM polymorphisms, pancreatic cancer risk and survival

artículo científico publicado en 2016

Biomarker analysis of the phase 3 TORCH trial for first line erlotinib versus chemotherapy in advanced non-small cell lung cancer patients

artículo científico publicado en 2017

Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer.

artículo científico publicado en 2015

Body mass index and prognosis in patients with head and neck cancer

artículo científico publicado en 2017

CHCHD2 Is Coamplified with EGFR in NSCLC and Regulates Mitochondrial Function and Cell Migration.

artículo científico publicado en 2015

CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis

artículo científico publicado en 2015

Canadian consensus: inhibition of ALK-positive tumours in advanced non-small-cell lung cancer

artículo científico publicado en 2016

Cancer patients acceptance, understanding, and willingness-to-pay for pharmacogenomic testing

Cancer patients' acceptability of incorporating an epidemiology questionnaire within a clinical trial

artículo científico publicado en 2015

Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation

artículo científico publicado en 2010

Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium

artículo científico publicado en 2014

Ceritinib in ALK-rearranged non-small-cell lung cancer

artículo científico publicado en 2014

Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial

artículo científico publicado en 2017

Cetuximab Inhibits T790M-Mediated Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in a Lung Adenocarcinoma Patient-Derived Xenograft Mouse Model.

artículo científico publicado en 2016

Circulating 25-Hydroxyvitamin D Levels Predict Survival in Early-Stage Non–Small-Cell Lung Cancer Patients

article

Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer

artículo científico publicado en 2008

Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes

artículo científico publicado en 2009

Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers

artículo científico publicado en 2016

Common TDP1 Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer Consortium

artículo científico publicado en 2017

Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus

artículo científico publicado en 2012

Comorbidity and performance status as independent prognostic factors in patients with head and neck squamous cell carcinoma

artículo científico publicado en 2014

Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status

artículo científico publicado en 2013

Comparative Efficacy of Ceritinib and Crizotinib as Initial ALK-Targeted Therapies in Previously Treated Advanced NSCLC: An Adjusted Comparison with External Controls

artículo científico publicado en 2016

Comparison of pathway analysis approaches using lung cancer GWAS data sets

artículo científico publicado en 2012

Correction: Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

artículo científico publicado en 2015

Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial

artículo científico publicado en 2014

Degree of tumor shrinkage following neoadjuvant chemoradiotherapy: a potential predictor for complete pathological response in esophageal cancer?

artículo científico publicado en 2012

Dietary iron, zinc, and calcium and the risk of lung cancer

artículo científico publicado en 2005

Dietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients

artículo científico publicado en 2010

Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcome.

artículo científico publicado en 2015

EQ-5D Health Utility Scores: Data from a Comprehensive Canadian Cancer Centre

artículo científico publicado en 2016

Early adulthood body mass index, cumulative smoking, and esophageal adenocarcinoma survival.

artículo científico publicado en 2017

Effect of Standard Radiotherapy With Cisplatin vs Accelerated Radiotherapy With Panitumumab in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma: A Randomized Clinical Trial

artículo científico publicado en 2016

Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

artículo científico publicado en 2015

Epidermal growth factor A61G gene polymorphism, gastroesophageal reflux disease and esophageal adenocarcinoma risk

artículo científico publicado en 2009

Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib.

artículo científico publicado en 2007

Erratum: Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer

scholarly article published in Nature Genetics

Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.

artículo científico publicado en 2004

Factors influencing a specific pathologic diagnosis of non-small-cell lung carcinoma

artículo científico publicado en 2013

Fc-γ Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer.

artículo científico publicado en 2016

Feasibility and diagnostic accuracy of the Patient-Reported Outcomes Measurement Information System (PROMIS) item banks for routine surveillance of sleep and fatigue problems in ambulatory cancer care

artículo científico publicado en 2016

Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma ⬇️

artículo científico publicado en 2012

Fine mapping of chromosome 5p15.33 based on a targeted deep sequencing and high density genotyping identifies novel lung cancer susceptibility loci

artículo científico publicado en 2016

Further insight into the markers of methotrexate resistance in childhood acute lymphoblastic leukemia patients

Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer

artículo científico publicado en 2005

Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes - A Meta-Analysis

artículo científico publicado en 2016

Genetic association analysis for common variants in the Genetic Analysis Workshop 18 data: a Dirichlet regression approach

artículo científico publicado en 2014

Genetic association analysis using weighted false discovery rate approach on Genetic Analysis Workshop 18 data

artículo científico publicado en 2014

Genetic associations with sporadic neuroendocrine tumor risk

artículo científico publicado en 2011

Genetic determinants of lung cancer prognosis in never smokers: A pooled analysis in the International Lung Cancer Consortium

artículo científico publicado en 2020

Genetic polymorphisms and head and neck cancer outcomes: a review

scientific article published on March 2008

Genetic polymorphisms as predictive and prognostic biomarkers in gynecological cancers: a systematic review

artículo científico publicado en 2011

Genetic polymorphisms of DNA repair genes and chromosomal damage in workers exposed to 1,3-butadiene

artículo científico publicado en 2010

Genetic polymorphisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk.

artículo científico publicado en 2008

Genetic polymorphisms of MnSOD, GSTM1, GSTT1, and OGG1 in coal workers' pneumoconiosis

artículo científico publicado en 2002

Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk

artículo científico publicado en 2008

Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancers

article

Genetic sequence variants in vitamin D metabolism pathway genes, serum vitamin D level and outcome in head and neck cancer patients

artículo científico publicado en 2012

Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group

artículo científico publicado en 2011

Genetic variation in radiation and platinum pathways predicts severe acute radiation toxicity in patients with esophageal adenocarcinoma treated with cisplatin-based preoperative radiochemotherapy: results from the Eastern Cooperative Oncology Group

artículo científico publicado en 2011

Genetic variations as cancer prognostic markers: review and update

artículo científico publicado en 2009

Genetic variations in esophageal cancer risk and prognosis

artículo científico publicado en 2009

Genome-wide DNA methylation profiling of cell-free serum DNA in esophageal adenocarcinoma and Barrett esophagus

artículo científico publicado en 2012

Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer

artículo científico publicado en 2016

Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis ⬇️

artículo científico publicado en 2016

Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer.

artículo científico publicado en 2005

Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux

artículo científico publicado en 2013

Germline genetic variation, cancer outcome, and pharmacogenetics

artículo científico publicado en 2010

Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma

artículo científico publicado en 2016

Haplotype approach for association analysis on hypertension

artículo científico publicado en 2014

Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma

artículo científico publicado en 2017

Human papillomavirus and host genetic polymorphisms in carcinogenesis: a systematic review and meta-analysis.

artículo científico

Human papillomavirus in oropharyngeal cancer in Canada: analysis of 5 comprehensive cancer centres using multiple imputation

artículo científico publicado en 2017

Identification of lung cancer histology-specific variants applying Bayesian framework variant prioritization approaches within the TRICL and ILCCO consortia

artículo científico publicado en 2015

Impact and Feasibility of a Comprehensive Geriatric Assessment in the Oncology Setting

Impact of Type 2 Diabetes Mellitus on Survival in Head and Neck Squamous Cell Carcinoma

artículo científico publicado en 2017

Implementation of a Novel Electronic Patient-Directed Smoking Cessation Platform for Cancer Patients: Interrupted Time Series Analysis

artículo científico publicado en 2019

Informed genome-wide association analysis with family history as a secondary phenotype identifies novel loci of lung cancer

artículo científico publicado en 2015

Integrated Omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact

artículo científico publicado en 2014

Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma

artículo científico publicado en 2014

Interaction of polymorphisms in mitotic regulator genes with cigarette smoking and pancreatic cancer risk

artículo científico publicado en 2013

Interactions among genetic variants in apoptosis pathway genes, reflux symptoms, body mass index, and smoking indicate two distinct etiologic patterns of esophageal adenocarcinoma

artículo científico publicado en 2010

Interactions between environmental factors and polymorphisms in angiogenesis pathway genes in esophageal adenocarcinoma risk: a case-only study

artículo científico publicado en 2011

Interactions between genetic polymorphisms in the apoptotic pathway and environmental factors on esophageal adenocarcinoma risk

artículo científico publicado en 2011

Investigation of Leukocyte Telomere Length and Genetic Variants in Chromosome 5p15.33 as Prognostic Markers in Lung Cancer

artículo científico publicado en 2019

Kernel machine SNP-set analysis for censored survival outcomes in genome-wide association studies

artículo científico publicado en 2011

Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations-a review

artículo científico

Lack of Correlation Between a Self-Administered Subjective GERD Questionnaire and Pathologic GERD Diagnosed by 24-h Esophageal pH Monitoring

Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes

artículo científico publicado en 2017

Lifestyle Behaviors in Elderly Cancer Survivors: A Comparison With Middle-Age Cancer Survivors

artículo científico publicado en 2015

MDM2 promoter polymorphism and pancreatic cancer risk and prognosis

journal article published in 2008

MDM2Polymorphism, Survival, and Histology in Early-Stage Non–Small-Cell Lung Cancer

article

MPO and SOD2 polymorphisms, gender, and the risk of non-small cell lung carcinoma.

artículo científico publicado en 2004

Managing skin toxicities related to panitumumab.

artículo científico

Manganese superoxide dismutase alanine-to-valine polymorphism at codon 16 and lung cancer risk.

artículo científico publicado en 2001

Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis

scientific article published on 25 March 2009

Matrix metalloproteinase polymorphisms and survival in stage I non-small cell lung cancer

journal article published in 2006

Matrix metalloproteinase-1 promoter polymorphism and lung cancer risk.

artículo científico publicado en 2005

Metabolic Suppression of a Drug-Resistant Subpopulation in Cancer Spheroid Cells.

artículo científico publicado en 2015

MiR-145 expression accelerates esophageal adenocarcinoma progression by enhancing cell invasion and anoikis resistance

artículo científico publicado en 2014

MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium ⬇️

artículo científico publicado en 2015

Modeling lung cancer risk in case-control studies using a new dose metric of smoking

artículo científico publicado en 2005

Molecular Profiling of Patients With Advanced Colorectal Cancer: Princess Margaret Cancer Centre Experience

artículo científico publicado en 2017

Molecular epidemiology of non-small cell lung cancer

artículo científico publicado en 2005

Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors

artículo científico publicado en 2016

Morphology of graft arteriosclerosis in cardiac transplant recipients

artículo científico publicado en 1992

Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma

artículo científico publicado en 2008

Neoadjuvant chemoradiotherapy for locally advanced thymic tumors: a phase II, multi-institutional clinical trial

artículo científico publicado en 2013

Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study

artículo científico publicado en 2014

Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study

artículo científico publicado en 2017

Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer

scientific article published on 06 November 2019

Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors.

scientific article published on August 2009

P53 (codon 72) and P21 (codon 31) polymorphisms alter in vivo mRNA expression of p21.

artículo científico publicado en 2003

Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study

artículo científico publicado en 2017

Patient preference: a comparison of electronic patient-completed questionnaires with paper among cancer patients

artículo científico publicado en 2015

Patient preferences for oral versus intravenous palliative chemotherapy

artículo científico publicado en 1997

Patient-Derived Xenograft Establishment from Human Malignant Pleural Mesothelioma.

artículo científico publicado en 2016

Patients with Advanced Non-Small Cell Lung Cancer: Are Research Biopsies a Barrier to Participation in Clinical Trials?

artículo científico

Pharmacogenetic analysis of BR.21, a placebo-controlled randomized phase III clinical trial of erlotinib in advanced non-small cell lung cancer.

artículo científico publicado en 2012

Pharmacogenetic and Germline Prognostic Markers of Lung Cancer

article

Pharmacokinetics and pharmacogenomics in breast cancer chemotherapy

scientific article published on 03 December 2008

Pharmacologic reversal of epigenetic silencing of the anticancer protein BRM: a novel targeted treatment strategy

artículo científico publicado en 2011

Phase 1/2 Study of the Addition of Cisplatin to Adjuvant Chemotherapy With Image Guided High-Precision Radiation Therapy for Completely Resected Gastric Cancer

artículo científico publicado en 2016

Phase II study of preoperative gefitinib in clinical stage I non-small-cell lung cancer

artículo científico publicado en 2009

Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma

artículo científico publicado en 2016

Plasma pro-surfactant protein B and lung function decline in smokers.

artículo científico publicado en 2015

Pleiotropy of genetic variants on obesity and smoking phenotypes: Results from the Oncoarray Project of The International Lung Cancer Consortium.

artículo científico publicado en 2017

Point-of-care outcome assessment in the cancer clinic: audit of data quality.

artículo científico publicado en 2010

Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients.

artículo científico publicado en 2005

Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinoma

artículo científico publicado en 2015

Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus ⬇️

artículo científico publicado en 2014

Polymorphisms of inflammatory and metalloproteinase genes, Helicobacter pylori infection and the risk of oesophageal adenocarcinoma

artículo científico publicado en 2008

Polymorphisms of the FOXF1 and MHC locus genes in individuals undergoing esophageal acid reflux assessments

artículo científico publicado en 2016

Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk

artículo científico publicado en 2008

Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients

artículo científico publicado en 2006

Predictive Tumor Biomarkers for EGFR Inhibitors

Predictors of severe acute and late toxicities in patients with localized head-and-neck cancer treated with radiation therapy

artículo científico publicado en 2011

Preferences for the Provision of Smoking Cessation Education Among Cancer Patients.

artículo científico publicado en 2016

Preservation of the 3D Phenotype Upon Dispersal of Cultured Cell Spheroids Into Monolayer Cultures.

artículo científico publicado en 2016

Previous lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer Consortium

artículo científico publicado en 2012

Primary esophageal and gastro-esophageal junction cancer xenograft models: clinicopathological features and engraftment

artículo científico publicado en 2013

Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signatures.

artículo científico publicado en 2010

Probability of cancer in pulmonary nodules detected on first screening CT.

artículo científico publicado en 2013

Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC).

artículo científico publicado en 2017

Prognostic factors for cure, recurrence and long-term survival after surgical resection of thymoma

artículo científico publicado en 2014

Protein-altering germline mutations implicate novel genes related to lung cancer development

scientific article published on 11 May 2020

Rare deleterious germline variants and risk of lung cancer

artículo científico publicado en 2021

Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer

scientific journal article

Real-World EQ5D Health Utility Scores for Patients With Metastatic Lung Cancer by Molecular Alteration and Response to Therapy

artículo científico publicado en 2016

Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium

artículo científico publicado en 2010

Resistance to bleomycin in cancer cell lines is characterized by prolonged doubling time, reduced DNA damage and evasion of G2/M arrest and apoptosis

artículo científico publicado en 2013

Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada

artículo científico publicado en 2014

Risk of esophageal adenocarcinoma decreases with height, based on consortium analysis and confirmed by Mendelian randomization ⬇️

artículo científico publicado en 2014

Risk of pancreatic cancer among individuals with a family history of cancer of the pancreas

artículo científico publicado en 2002

Second hand smoke exposure and survival in early-stage non-small-cell lung cancer patients

journal article published in 2006

Second hand smoke, age of exposure and lung cancer risk

artículo científico publicado en 2008

Second-hand smoke as a predictor of smoking cessation among lung cancer survivors.

artículo científico publicado en 2014

Serum Prognostic Markers in Head and Neck Cancer

Serum Proteomic Classifier for Predicting Response to Epidermal Growth Factor Receptor Inhibitor Therapy: Have We Built a Better Mousetrap?

article

Serum levels of tumor necrosis factor-α (TNF-α), interleukin 6 (IL-6), and their soluble receptors in coal workers' pneumoconiosis

artículo científico publicado en 2002

Should oncologists measure the mRNA and protein expression levels of ERCC1 and RRM1 in non-small-cell lung cancer?

Single nucleotide polymorphisms in the matrix metalloproteinase gene family and the frequency and duration of gastroesophageal reflux disease influence the risk of esophageal adenocarcinoma

artículo científico publicado en 2012

Smoking cessation before diagnosis and survival in early stage non-small cell lung cancer patients

artículo científico publicado en 2006

Social environment, secondary smoking exposure, and smoking cessation among head and neck cancer patients.

artículo científico publicado en 2013

Socioeconomic status and lifestyle behaviours in cancer survivors: smoking and physical activity

artículo científico publicado en 2016

Soluble Mesothelin-Related Peptide and Osteopontin As Markers of Response in Malignant Mesothelioma

article

Special considerations in prognostic research in cancer involving genetic polymorphisms

artículo científico publicado en 2013

Studying genetic variations in cancer prognosis (and risk): a primer for clinicians

scientific article published on 06 July 2009

Systematic Review of Genetic Variation in Chromosome 5p15.33 and Telomere Length as Predictive and Prognostic Biomarkers for Lung Cancer

artículo científico publicado en 2016

The Association of Family History of Cancer and Medical History With Pancreatic Cancer Risk

The Cost-Effectiveness of High-Risk Lung Cancer Screening and Drivers of Program Efficiency.

artículo científico publicado en 2017

The SOD2 Val/Val genotype enhances the risk of nonsmall cell lung carcinoma by p53 and XRCC1 polymorphisms.

artículo científico publicado en 2004

The causal relevance of body mass index in different histological types of lung cancer: A Mendelian randomization study

artículo científico publicado en 2016

The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre

artículo científico publicado en 2013

The prevalence and nature of supportive care needs in lung cancer patients

artículo científico publicado en 2016

The role of second-hand smoke exposure on smoking cessation in non-tobacco-related cancers

artículo científico publicado en 2015

The vascular pathology of human hepatic allografts

scientific article published on 01 February 1993

Treatment of the elderly when cure is the goal: the influence of age on treatment selection and efficacy for stage III non-small cell lung cancer.

artículo científico publicado en 2011

Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancer

artículo científico publicado en 2017

Treatment patterns and survival in patients with ALK-positive non-small-cell lung cancer: a Canadian retrospective study

artículo científico publicado en 2016

Two BRM promoter insertion polymorphisms increase the risk of early-stage upper aerodigestive tract cancers.

artículo científico publicado en 2014

Two BRM promoter polymorphisms predict poor survival in patients with hepatocellular carcinoma.

artículo científico publicado en 2017

Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk.

artículo científico publicado en 2011

Uncommon EGFR mutations in advanced non-small cell lung cancer

artículo científico publicado en 2017

Usability Evaluation of a Mobile Phone-Based System for Remote Monitoring and Management of Chemotherapy-Related Side Effects in Cancer Patients: Mixed-Methods Study

artículo científico publicado en 2018

VEGF pathway polymorphisms as prognostic and pharmacogenetic factors in cancer: a 2013 update

artículo científico

VEGF polymorphisms and survival in early-stage non-small-cell lung cancer

artículo científico publicado en 2008

Validation of a one-page patient-reported Charlson comorbidity index questionnaire for upper aerodigestive tract cancer patients.

artículo científico publicado en 2013

Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival

artículo científico publicado en 2011

Validation of microRNA pathway polymorphisms in esophageal adenocarcinoma survival

artículo científico publicado en 2017

Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer

journal article published in 2008

Vascular endothelial growth factor pathway polymorphisms as prognostic and pharmacogenetic factors in cancer: a systematic review and meta-analysis

artículo científico

Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis

artículo científico publicado en 2009

Vitamin D is associated with improved survival in early-stage non-small cell lung cancer patients

artículo científico publicado en 2005

Whole-miRNome profiling identifies prognostic serum miRNAs in esophageal adenocarcinoma: the influence of Helicobacter pylori infection status

artículo científico publicado en 2014

XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy

artículo científico publicado en 2004

XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk.

artículo científico publicado en 2007

p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis

artículo científico publicado en 2009

p53 Arg72Pro polymorphism, HPV status and initiation, progression, and development of cervical cancer: a systematic review and meta-analysis

artículo científico publicado en 2012

p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma

artículo científico publicado en 2009

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda